ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 400 mcg/actuation - fluticasone - fluticasone - flixonase nasule drops are indicated for the regular treatment of nasal polyps and associated symptoms of nasal obstruction.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 g / 100 g - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hayfever, and perennial rhinitis. perenial rhinitis in children of the age of 4 years.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף לשאיפה לערפול - fluticasone propionate 0.5 mg / 2 ml - fluticasone - fluticasone - in adults and adolescents over 16 years flixotide nebules can be used:for prophylactic management of severe chronic asthma in patients requiring high dose inhaled or oral corticosteroid therapy. it reduces symptoms and exacerbations of asthma in patients previously treated with other prophylactic therapy.children and adolescents from 4 to 16 years of age:treatment of acute exacerbations of asthma.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף לשאיפה לערפול - fluticasone propionate 2 mg / 2 ml - fluticasone - fluticasone - in adults and adolescents over 16 years flixotide nebules can be used:for prophylactic management of severe chronic asthma in patients requiring high dose inhaled or oral corticosteroid therapy. it reduces symptoms and exacerbations of asthma in patients previously treated with other prophylactic therapy.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - אבקה לשאיפה - fluticasone propionate 100 mcg - fluticasone

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 %w/w - fluticasone

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תמיסה לאף - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hay fever and perenial rhinitis.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 100 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of severe and moderate reversible obstructive airways disease ( road) , including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 500 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of severe and moderate reversible obstructive airways disease ( road) , including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. extension of copd indication for seretide diskus:seretide is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate; salmeterol as xinafoate - אבקה לשאיפה - fluticasone propionate 250 mcg; salmeterol as xinafoate 50 mcg - salmeterol and other drugs for obstructive airway diseases - salmeterol and other drugs for obstructive airway diseases - seretide is indicated in the regular treatment of severe and moderate reversible obstructive airways disease ( road) , including asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate. extension of copd indication for seretide diskus:seretide is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy.